Study on Combining Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Localized Liver Cancer | Clinical Trial

Study on Combining Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Localized Liver Cancer | Clinical Trial | Right2Hope